Bionano Overview
- Year Founded
-
2003
- Status
-
Public
- Employees
-
344
- Stock Symbol
-
BNGO
- Investments
-
3
- Share Price
-
$1.14
- (As of Friday Closing)
Bionano General Information
Description
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
Contact Information
Website
www.bionano.comCorporate Office
- 9540 Towne Centre Drive
- Suite 100
- San Diego, CA 92121
- United States
Bionano Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.14 | $1.11 | $0.71 - $8.20 | $76.2M | 66.9M | 1.42M | -$17.18 |
Bionano Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 38,235 | 19,968 | 263,712 | 538,591 |
| Revenue | 37,470 | 36,116 | 27,802 | 17,981 |
| EBITDA | (216,711) | (122,081) | (74,091) | |
| Net Income | (226,791) | (232,493) | (132,596) | (72,435) |
| Total Assets | 157,995 | 214,404 | 307,502 | 377,100 |
| Total Debt | 37,869 | 79,413 | 11,668 | 10,696 |
Bionano Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Bionano Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Bionano Comparisons
Industry
Financing
Details
00000
00000
Bionano Competitors (35)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Akoya Biosciences | Formerly VC-backed | Marlborough, MA | 000 | 00000 | 00000000 | 00000 |
| Cytek | Formerly VC-backed | Fremont, CA | 000 | 00000 | 00000000 | 00000 |
| Diagenode | Formerly VC-backed | Seraing, Belgium | 000 | 00.000 | 000000&0 | 00.000 |
| Illumina | Formerly VC-backed | San Diego, CA | 0000 | 00.000 | 0000 | 00.000 |
| Standard BioTools | Formerly VC-backed | San Francisco, CA | 000 | 00000 | 00000000000 | 00000 |
Bionano Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Bionano Patents
Bionano Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210230664-A1 | Labeling of dna | Pending | 25-Jun-2018 | 0000000000 | 0 |
| EP-4159872-A1 | Labeling of dna | Pending | 25-Jun-2018 | 0000000000 | 0 |
| EP-3810801-A1 | Labeling of dna | Active | 25-Jun-2018 | 0000000000 | |
| EP-3810801-B1 | Labeling of dna | Active | 25-Jun-2018 | 0000000000 | |
| CA-3104649-A1 | Labeling of dna | Pending | 25-Jun-2018 | C12Q1/6841 |
Bionano Executive Team (24)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| R. Holmlin Ph.D | President And Chief Executive Officer | ||
| Gulsen Kama | Chief Financial Officer, Finance & Chief Accounting Officer, Accounting | ||
| Mark Oldakowski | Chief Operating Officer, Operations | ||
| Helene Klein | Chief People Officer | ||
| Sean Paolino | Vice President, Finance |
Bionano Board Members (12)
| Name | Representing | Role | Since |
|---|---|---|---|
| Albert Luderer Ph.D | Self | Board Member | 000 0000 |
| Brian Halak Ph.D | Domain Associates | Board Member | 000 0000 |
| Campbell Murray MD | Novartis Venture Fund | Board Observer | 000 0000 |
| Christopher Twomey | Self | Board Member | 000 0000 |
| Daqing Cai Ph.D | Legend Capital | Board Member | 000 0000 |
Bionano Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Bionano Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Purigen Biosystems | 30-Nov-2022 | 0000000000 | 000.00 | Biotechnology | 0. 000000 |
| BioDiscovery | 18-Oct-2021 | 0000000000 | 000.00 | Outcome Management (Healthcare) | 0. 000000 |
| Lineagen | 21-Aug-2020 | Merger/Acquisition | 00.000 | Other Healthcare Technology Systems | 0. 000000 |
Bionano Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Purigen Biosystems | Biotechnology | Pleasanton, CA | 2012 |
| BioDiscovery | Outcome Management (Healthcare) | El Segundo, CA | 0000 |
Bionano ESG
Risk Overview
Risk Rating
Updated April, 28, 2023
29.35 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.0
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,708
Rank
Percentile
Pharmaceuticals
Industry
00 of 884
Rank
Percentile
Biotechnology
Subindustry
00 of 399
Rank
Percentile
Bionano FAQs
-
When was Bionano founded?
Bionano was founded in 2003.
-
Who is the founder of Bionano?
Han Cao Ph.D is the founder of Bionano.
-
Who is the CEO of Bionano?
R. Holmlin Ph.D is the CEO of Bionano.
-
Where is Bionano headquartered?
Bionano is headquartered in San Diego, CA.
-
What is the size of Bionano?
Bionano has 344 total employees.
-
What industry is Bionano in?
Bionano’s primary industry is Biotechnology.
-
Is Bionano a private or public company?
Bionano is a Public company.
-
What is Bionano’s stock symbol?
The ticker symbol for Bionano is BNGO.
-
What is the current stock price of Bionano?
As of 17-May-2024 the stock price of Bionano is $1.14.
-
What is the current market cap of Bionano?
The current market capitalization of Bionano is $76.2M.
-
What is Bionano’s current revenue?
The trailing twelve month revenue for Bionano is $37.5M.
-
Who are Bionano’s competitors?
Akoya Biosciences, Cytek, Diagenode, Illumina, and Standard BioTools are some of the 35 competitors of Bionano.
-
What is Bionano’s annual earnings per share (EPS)?
Bionano’s EPS for 12 months was -$17.18.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
